Global Oncology Drugs Market Insights and Forecast to 2031

Report ID: 1550140 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy (Biologic Therapy)
        1.2.5 Hormonal Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory or Lung Cancer
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncology Drugs Market Perspective (2017-2028)
    2.2 Oncology Drugs Growth Trends by Region
        2.2.1 Oncology Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncology Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Oncology Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Oncology Drugs Market Dynamics
        2.3.1 Oncology Drugs Industry Trends
        2.3.2 Oncology Drugs Market Drivers
        2.3.3 Oncology Drugs Market Challenges
        2.3.4 Oncology Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncology Drugs Players by Revenue
        3.1.1 Global Top Oncology Drugs Players by Revenue (2017-2022)
        3.1.2 Global Oncology Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncology Drugs Revenue
    3.4 Global Oncology Drugs Market Concentration Ratio
        3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2021
    3.5 Oncology Drugs Key Players Head office and Area Served
    3.6 Key Players Oncology Drugs Product Solution and Service
    3.7 Date of Enter into Oncology Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drugs Breakdown Data by Type
    4.1 Global Oncology Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Oncology Drugs Forecasted Market Size by Type (2023-2028)
5 Oncology Drugs Breakdown Data by Application
    5.1 Global Oncology Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Oncology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncology Drugs Market Size (2017-2028)
    6.2 North America Oncology Drugs Market Size by Type
        6.2.1 North America Oncology Drugs Market Size by Type (2017-2022)
        6.2.2 North America Oncology Drugs Market Size by Type (2023-2028)
        6.2.3 North America Oncology Drugs Market Share by Type (2017-2028)
    6.3 North America Oncology Drugs Market Size by Application
        6.3.1 North America Oncology Drugs Market Size by Application (2017-2022)
        6.3.2 North America Oncology Drugs Market Size by Application (2023-2028)
        6.3.3 North America Oncology Drugs Market Share by Application (2017-2028)
    6.4 North America Oncology Drugs Market Size by Country
        6.4.1 North America Oncology Drugs Market Size by Country (2017-2022)
        6.4.2 North America Oncology Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Oncology Drugs Market Size (2017-2028)
    7.2 Europe Oncology Drugs Market Size by Type
        7.2.1 Europe Oncology Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Oncology Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Oncology Drugs Market Share by Type (2017-2028)
    7.3 Europe Oncology Drugs Market Size by Application
        7.3.1 Europe Oncology Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Oncology Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Oncology Drugs Market Share by Application (2017-2028)
    7.4 Europe Oncology Drugs Market Size by Country
        7.4.1 Europe Oncology Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Oncology Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncology Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Oncology Drugs Market Size by Type
        8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oncology Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oncology Drugs Market Size by Application
        8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oncology Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oncology Drugs Market Size by Region
        8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oncology Drugs Market Size (2017-2028)
    9.2 Latin America Oncology Drugs Market Size by Type
        9.2.1 Latin America Oncology Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Oncology Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Oncology Drugs Market Share by Type (2017-2028)
    9.3 Latin America Oncology Drugs Market Size by Application
        9.3.1 Latin America Oncology Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Oncology Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Oncology Drugs Market Share by Application (2017-2028)
    9.4 Latin America Oncology Drugs Market Size by Country
        9.4.1 Latin America Oncology Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Oncology Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncology Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Oncology Drugs Market Size by Type
        10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oncology Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oncology Drugs Market Size by Application
        10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oncology Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oncology Drugs Market Size by Country
        10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Oncology Drugs Introduction
        11.1.4 Roche Revenue in Oncology Drugs Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene Oncology Drugs Introduction
        11.2.4 Celgene Revenue in Oncology Drugs Business (2017-2022)
        11.2.5 Celgene Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Oncology Drugs Introduction
        11.3.4 Novartis Revenue in Oncology Drugs Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Oncology Drugs Introduction
        11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Merck & Co.
        11.6.1 Merck & Co. Company Details
        11.6.2 Merck & Co. Business Overview
        11.6.3 Merck & Co. Oncology Drugs Introduction
        11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2017-2022)
        11.6.5 Merck & Co. Recent Developments
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Details
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Oncology Drugs Introduction
        11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2017-2022)
        11.7.5 AstraZeneca Recent Developments
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Oncology Drugs Introduction
        11.8.4 Pfizer Revenue in Oncology Drugs Business (2017-2022)
        11.8.5 Pfizer Recent Developments
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Oncology Drugs Introduction
        11.9.4 Amgen Revenue in Oncology Drugs Business (2017-2022)
        11.9.5 Amgen Recent Developments
    11.10 Eli Lilly
        11.10.1 Eli Lilly Company Details
        11.10.2 Eli Lilly Business Overview
        11.10.3 Eli Lilly Oncology Drugs Introduction
        11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2017-2022)
        11.10.5 Eli Lilly Recent Developments
    11.11 AbbVie
        11.11.1 AbbVie Company Details
        11.11.2 AbbVie Business Overview
        11.11.3 AbbVie Oncology Drugs Introduction
        11.11.4 AbbVie Revenue in Oncology Drugs Business (2017-2022)
        11.11.5 AbbVie Recent Developments
    11.12 Takeda
        11.12.1 Takeda Company Details
        11.12.2 Takeda Business Overview
        11.12.3 Takeda Oncology Drugs Introduction
        11.12.4 Takeda Revenue in Oncology Drugs Business (2017-2022)
        11.12.5 Takeda Recent Developments
    11.13 Astellas
        11.13.1 Astellas Company Details
        11.13.2 Astellas Business Overview
        11.13.3 Astellas Oncology Drugs Introduction
        11.13.4 Astellas Revenue in Oncology Drugs Business (2017-2022)
        11.13.5 Astellas Recent Developments
    11.14 Ipsen
        11.14.1 Ipsen Company Details
        11.14.2 Ipsen Business Overview
        11.14.3 Ipsen Oncology Drugs Introduction
        11.14.4 Ipsen Revenue in Oncology Drugs Business (2017-2022)
        11.14.5 Ipsen Recent Developments
    11.15 Sanofi
        11.15.1 Sanofi Company Details
        11.15.2 Sanofi Business Overview
        11.15.3 Sanofi Oncology Drugs Introduction
        11.15.4 Sanofi Revenue in Oncology Drugs Business (2017-2022)
        11.15.5 Sanofi Recent Developments
    11.16 Bayer
        11.16.1 Bayer Company Details
        11.16.2 Bayer Business Overview
        11.16.3 Bayer Oncology Drugs Introduction
        11.16.4 Bayer Revenue in Oncology Drugs Business (2017-2022)
        11.16.5 Bayer Recent Developments
    11.17 Biogen Idec
        11.17.1 Biogen Idec Company Details
        11.17.2 Biogen Idec Business Overview
        11.17.3 Biogen Idec Oncology Drugs Introduction
        11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2017-2022)
        11.17.5 Biogen Idec Recent Developments
    11.18 Teva
        11.18.1 Teva Company Details
        11.18.2 Teva Business Overview
        11.18.3 Teva Oncology Drugs Introduction
        11.18.4 Teva Revenue in Oncology Drugs Business (2017-2022)
        11.18.5 Teva Recent Developments
    11.19 Otsuka
        11.19.1 Otsuka Company Details
        11.19.2 Otsuka Business Overview
        11.19.3 Otsuka Oncology Drugs Introduction
        11.19.4 Otsuka Revenue in Oncology Drugs Business (2017-2022)
        11.19.5 Otsuka Recent Developments
    11.20 Eisai
        11.20.1 Eisai Company Details
        11.20.2 Eisai Business Overview
        11.20.3 Eisai Oncology Drugs Introduction
        11.20.4 Eisai Revenue in Oncology Drugs Business (2017-2022)
        11.20.5 Eisai Recent Developments
    11.21 Merck KGaA
        11.21.1 Merck KGaA Company Details
        11.21.2 Merck KGaA Business Overview
        11.21.3 Merck KGaA Oncology Drugs Introduction
        11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2017-2022)
        11.21.5 Merck KGaA Recent Developments
    11.22 Gilead Sciences
        11.22.1 Gilead Sciences Company Details
        11.22.2 Gilead Sciences Business Overview
        11.22.3 Gilead Sciences Oncology Drugs Introduction
        11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2017-2022)
        11.22.5 Gilead Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Immunotherapy (Biologic Therapy)
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Others
    Table 7. Global Oncology Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Oncology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Oncology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Oncology Drugs Market Share by Region (2017-2022)
    Table 11. Global Oncology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Oncology Drugs Market Share by Region (2023-2028)
    Table 13. Oncology Drugs Market Trends
    Table 14. Oncology Drugs Market Drivers
    Table 15. Oncology Drugs Market Challenges
    Table 16. Oncology Drugs Market Restraints
    Table 17. Global Oncology Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Oncology Drugs Revenue Share by Players (2017-2022)
    Table 19. Global Top Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2021)
    Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Drugs Product Solution and Service
    Table 24. Date of Enter into Oncology Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Oncology Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Oncology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Oncology Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Oncology Drugs Revenue Share by Application (2017-2022)
    Table 32. Global Oncology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Oncology Drugs Revenue Share by Application (2023-2028)
    Table 34. North America Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Oncology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Oncology Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Oncology Drugs Product
    Table 67. Roche Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 68. Roche Recent Developments
    Table 69. Celgene Company Details
    Table 70. Celgene Business Overview
    Table 71. Celgene Oncology Drugs Product
    Table 72. Celgene Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 73. Celgene Recent Developments
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Oncology Drugs Product
    Table 77. Novartis Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 78. Novartis Recent Developments
    Table 79. Bristol-Myers Squibb Company Details
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb Oncology Drugs Product
    Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Developments
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Oncology Drugs Product
    Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 88. Johnson & Johnson Recent Developments
    Table 89. Merck & Co. Company Details
    Table 90. Merck & Co. Business Overview
    Table 91. Merck & Co. Oncology Drugs Product
    Table 92. Merck & Co. Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 93. Merck & Co. Recent Developments
    Table 94. AstraZeneca Company Details
    Table 95. AstraZeneca Business Overview
    Table 96. AstraZeneca Oncology Drugs Product
    Table 97. AstraZeneca Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 98. AstraZeneca Recent Developments
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Oncology Drugs Product
    Table 102. Pfizer Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 103. Pfizer Recent Developments
    Table 104. Amgen Company Details
    Table 105. Amgen Business Overview
    Table 106. Amgen Oncology Drugs Product
    Table 107. Amgen Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 108. Amgen Recent Developments
    Table 109. Eli Lilly Company Details
    Table 110. Eli Lilly Business Overview
    Table 111. Eli Lilly Oncology Drugs Product
    Table 112. Eli Lilly Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 113. Eli Lilly Recent Developments
    Table 114. AbbVie Company Details
    Table 115. AbbVie Business Overview
    Table 116. AbbVie Oncology Drugs Product
    Table 117. AbbVie Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 118. AbbVie Recent Developments
    Table 119. Takeda Company Details
    Table 120. Takeda Business Overview
    Table 121. Takeda Oncology Drugs Product
    Table 122. Takeda Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 123. Takeda Recent Developments
    Table 124. Astellas Company Details
    Table 125. Astellas Business Overview
    Table 126. Astellas Oncology Drugs Product
    Table 127. Astellas Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 128. Astellas Recent Developments
    Table 129. Ipsen Company Details
    Table 130. Ipsen Business Overview
    Table 131. Ipsen Oncology Drugs Product
    Table 132. Ipsen Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 133. Ipsen Recent Developments
    Table 134. Sanofi Company Details
    Table 135. Sanofi Business Overview
    Table 136. Sanofi Oncology Drugs Product
    Table 137. Sanofi Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 138. Sanofi Recent Developments
    Table 139. Bayer Company Details
    Table 140. Bayer Business Overview
    Table 141. Bayer Oncology Drugs Product
    Table 142. Bayer Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 143. Bayer Recent Developments
    Table 144. Biogen Idec Company Details
    Table 145. Biogen Idec Business Overview
    Table 146. Biogen Idec Oncology Drugs Product
    Table 147. Biogen Idec Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 148. Biogen Idec Recent Developments
    Table 149. Teva Company Details
    Table 150. Teva Business Overview
    Table 151. Teva Oncology Drugs Product
    Table 152. Teva Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 153. Teva Recent Developments
    Table 154. Otsuka Company Details
    Table 155. Otsuka Business Overview
    Table 156. Otsuka Oncology Drugs Product
    Table 157. Otsuka Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 158. Otsuka Recent Developments
    Table 159. Eisai Company Details
    Table 160. Eisai Business Overview
    Table 161. Eisai Oncology Drugs Product
    Table 162. Eisai Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 163. Eisai Recent Developments
    Table 164. Merck KGaA Company Details
    Table 165. Merck KGaA Business Overview
    Table 166. Merck KGaA Oncology Drugs Product
    Table 167. Merck KGaA Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 168. Merck KGaA Recent Developments
    Table 169. Gilead Sciences Company Details
    Table 170. Gilead Sciences Business Overview
    Table 171. Gilead Sciences Oncology Drugs Product
    Table 172. Gilead Sciences Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
    Table 173. Gilead Sciences Recent Developments
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Targeted Therapy Features
    Figure 4. Immunotherapy (Biologic Therapy) Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Others Features
    Figure 7. Global Oncology Drugs Market Share by Application: 2021 VS 2028
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Respiratory or Lung Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. Oncology Drugs Report Years Considered
    Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Oncology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Oncology Drugs Market Share by Region: 2021 VS 2028
    Figure 18. Global Oncology Drugs Market Share by Players in 2021
    Figure 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2021
    Figure 21. North America Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Oncology Drugs Market Size Market Share by Type (2017-2028)
    Figure 23. North America Oncology Drugs Market Size Market Share by Application (2017-2028)
    Figure 24. North America Oncology Drugs Market Size Share by Country (2017-2028)
    Figure 25. United States Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Oncology Drugs Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Oncology Drugs Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Oncology Drugs Market Size Share by Country (2017-2028)
    Figure 31. Germany Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Oncology Drugs Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Oncology Drugs Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Oncology Drugs Market Size Share by Region (2017-2028)
    Figure 41. China Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Latin America Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Oncology Drugs Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Oncology Drugs Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Oncology Drugs Market Size Share by Country (2017-2028)
    Figure 51. Mexico Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Oncology Drugs Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Oncology Drugs Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Oncology Drugs Market Size Share by Country (2017-2028)
    Figure 57. Turkey Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 61. Celgene Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 65. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 66. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 67. Pfizer Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 68. Amgen Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 69. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 70. AbbVie Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 71. Takeda Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 72. Astellas Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 73. Ipsen Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 74. Sanofi Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 75. Bayer Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 76. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 77. Teva Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 78. Otsuka Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 79. Eisai Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 80. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 81. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2017-2022)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Frequently Asked Questions
Oncology Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lymphoma Drugs

Lymphoma Drugs market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Grain Fumigants

Grain Fumigants market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More